Stream every public session from the 27th annual Global Conference right here on our website.

Watch Here
results for:

Content Type

Centers and Programs

Topics

Tags

Refine by Date

8
FasterCures Quarterly Update: July 2023 article
FasterCures Quarterly Update: July 2023
In This Issue: Convenings Recap Policy Updates FasterCures in the Media FasterCures in the Communit
y
Jul 13, 2023
FasterCures Statement of Support for 21st Century Cures 2.0 Legislation article
FasterCures Statement of Support for 21st Century Cures 2.0 Legislation
FasterCures, a center of the Milken Institute, has long supported policies that accelerate new, cutt
ing-edge biomedical innovations to patients.
Nov 16, 2021
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief report
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief
The Milken Institute Center for Public Health and FasterCures have identified three PAHPA 2023 poli
cy priorities that are core to improving and strengthening the nation’s biosecurity and preparedness infrastructure.
Jul 21, 2023
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development report
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development
New blood-based technologies, known as multi-cancer early detection (MCED) tests, are entering&nbsp
;the market and can identify multiple cancers early and simultaneously.
Nov 3, 2021
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap report
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical i
nnovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible.
Nov 19, 2021
Achieving Health Equity: A Multi-Stakeholder Action Plan to Address Diversity across the Clinical Trials Enterprise and the Biomedical Research Ecosystem report
Achieving Health Equity: A Multi-Stakeholder Action Plan to Address Diversity across the Clinical Trials Enterprise and the Biomedical Research Ecosystem
Clinical trials have been used for decades as the primary way by which researchers determine if a n
ew treatment is safe and effective for human use.
Nov 18, 2021
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870 article
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
Submitted electronically Dr. Robert Califf Commissioner US Food and Drug Administration Silver Spri
ng, MD 20993 Dear Dr. Califf,
Jul 31, 2023
Discussion Draft of the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization article
Discussion Draft of the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
Submitted electronically 
Jul 10, 2023